The FDA approved Wegovy for use in a form of liver disease.
Novo Nordisk shares are rising. The FDA approves another use for Wegovy.
About the author
BREAKING NEWS
- The key to being confident in an uncertain market, according to a CFP: ‘Always be calibrating’
- Archaeologists Dug Beneath a Farm—and Found a Smiling Ancient Face
- Russia Immediately Dumps Cold Water on Trump’s Ukraine Wins
- Why the rally on Wall Street could be running out of steam
- Viking Therapeutics’ stock tumbles after results of oral weight-loss drug trial. It has company.
- Air France flight makes emergency landing at JFK Airport
